CVSCVS Health

$83.84+11% 1Y

Operating metrics

Medical membership at CVS Health: 26.12M for Q3 2026, −2.2% on a year ago.

Operating metrics

From earnings releases, Q3 2021 to Q3 2026
Medical membership, Q3 202626.12M

−2.2% on a year ago

Medical benefit ratio91.3%

Q3 2026, −1.5 points on a year ago

Prescriptions filled470.0M

Q3 2026, +1.9% on a year ago

Medical membership, Q3 2026: 26.12M

Total medical membership9,91916,20126,1209,82916,19426,02310,86815,72326,59111,00115,70226,703

Source: Q3 2026 earnings release, filed Nov 4, 2026

Every quarter, with its source

QuarterMedical membershipMedical benefit ratioPrescriptions filledRelease
Q3 202626.12M91.3%470.0MFiled Nov 4, 2026
Q2 202626.02M87.4%457.0MFiled Aug 5, 2026
Q1 202626.00M84.6%451.2MFiled May 6, 2026
Q4 202526.59M94.8%473.8MFiled Feb 10, 2026
Q3 202526.70M92.8%461.4MFiled Oct 29, 2025
Q2 202526.72M89.9%438.1MFiled Jul 31, 2025
Q1 202527.08M87.3%435.5MFiled May 1, 2025
Q4 202427.09M94.8%445.9MFiled Feb 12, 2025
Q3 202427.15M95.2%431.6MFiled Nov 6, 2024
Q2 202426.97M89.6%420.4MFiled Aug 7, 2024
Q1 202426.77M90.4%417.6MFiled May 1, 2024
Q4 202325.66M88.5%431.5MFiled Feb 7, 2024
Q3 202325.69M85.7%407.1MFiled Nov 1, 2023
Q2 202325.63M86.2%405.7MFiled Aug 2, 2023
Q1 202325.51M84.6%404.8MFiled May 3, 2023
Q4 202224.40M86.0%423.1MFiled Feb 8, 2023
Q3 202224.29M83.5%405.3MFiled Nov 2, 2022
Q2 202224.43M82.9%400.8MFiled Aug 3, 2022
Q1 202224.52M83.5%394.6MFiled May 4, 2022
Q4 202123.85M87.0%419.8MFiled Feb 9, 2022
Q3 202123.70M85.8%398.0MFiled Nov 3, 2021
Medical membership
Members covered by Aetna insured and administrative-services-only medical products at quarter end.
Medical benefit ratio
Health Care Benefits segment health care costs as a percentage of premium revenues.
Prescriptions filled
Prescriptions filled at CVS retail and long-term care pharmacies in the quarter, 30-day equivalent.

Source: company earnings releases furnished to the SEC on Form 8-K (Item 2.02, Exhibit 99), SEC EDGAR.

CVS Health (CVS) Key Metrics: Medical Membership and Medical Benefit Ratio by Quarter · Ryufin